Cargando…
Inhibition of autophagy enhances the cytotoxic effect of PA-MSHA in breast cancer
BACKGROUND: PA-MSHA, a genetically engineered Pseudomonas aeruginosa (PA) strain, is currently under investigation as a new anti-cancer drug. It can induce cell cycle arrest and apoptosis in different human cancer cells, including hormone receptor negative breast cancer cells. However, the underlyin...
Autores principales: | Xu, Wen-Huan, Liu, Zhe-Bin, Hou, Yi-Feng, Hong, Qi, Hu, Da-Li, Shao, Zhi-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4000616/ https://www.ncbi.nlm.nih.gov/pubmed/24745346 http://dx.doi.org/10.1186/1471-2407-14-273 |
Ejemplares similares
-
PA-MSHA induces inflamed tumor microenvironment and sensitizes tumor to anti-PD-1 therapy
por: Huang, Min, et al.
Publicado: (2022) -
Neoadjuvant Pseudomonas aeruginosa mannose-sensitive hemagglutinin (PA-MSHA) and chemotherapy versus placebo plus chemotherapy in patients with HER2-negative breast cancer: a randomized, controlled, double-blind trial
por: Gong, Yue, et al.
Publicado: (2023) -
PA-MSHA induces apoptosis and suppresses metastasis by tumor associated macrophages in bladder cancer cells
por: Liu, Jianjun, et al.
Publicado: (2017) -
PA‐MSHA inhibits the growth of doxorubicin‐resistant MCF‐7/ADR human breast cancer cells by downregulating Nrf2/p62
por: Wei, Yingze, et al.
Publicado: (2016) -
PA-MSHA in combination with EGFR tyrosine kinase inhibitor: A new strategy to overcome the drug resistance of non-small cell lung cancer cells
por: Zhao, Xin-min, et al.
Publicado: (2016)